Genetics and cytogenetics of retinoblastoma.
暂无分享,去创建一个
[1] A. Hogg,et al. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. , 1992, Oncogene.
[2] A. Hogg,et al. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Cowell,et al. Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene. , 1992, British Journal of Cancer.
[4] B. Gallie,et al. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. , 1992, Cancer research.
[5] M. Ewen,et al. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner , 1992, Cell.
[6] L. Tsai,et al. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F , 1992, Nature.
[7] M. Ewen,et al. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. , 1992, Science.
[8] W. Lee,et al. Intraocular tumor suppression of retinoblastoma gene-reconstituted retinoblastoma cells. , 1991, Cancer research.
[9] M. Knowles,et al. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. , 1991, Oncogene.
[10] A. Condie,et al. A familial RB1 mutation detected by the HOT technique is homozygous in a second primary neoplasm. , 1991, Oncogene.
[11] N. L. La Thangue,et al. A developmentally regulated and tissue‐dependent transcription factor complexes with the retinoblastoma gene product. , 1991, The EMBO journal.
[12] Y. Qian,et al. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.
[13] S. Maeda,et al. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. , 1991, Cancer research.
[14] S. Hirohashi,et al. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. , 1991, Cancer research.
[15] Patricia L. Blount,et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.
[16] M. Ewen,et al. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein , 1991, Cell.
[17] T. Hunter,et al. Cyclins and cancer , 1991, Cell.
[18] T. L. McGee,et al. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene , 1991, Nature.
[19] G. Klein,et al. Intraocular tumor formation of RB reconstituted retinoblastoma cells. , 1991, Cancer research.
[20] A. Rustgi,et al. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.
[21] M. Belvin,et al. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells. , 1991, Oncogene.
[22] Pearl S Huang,et al. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product , 1991, Nature.
[23] T. Hunt,et al. Cyclin A and the retinoblastoma gene product complex with a common transcription factor , 1991, Nature.
[24] J. Nevins,et al. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A , 1991, Cell.
[25] W. Kaelin,et al. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein , 1991, Cell.
[26] Joseph R. Nevins,et al. The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.
[27] R. Weinmann,et al. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F , 1991, Cell.
[28] N. L. Thangue,et al. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor , 1991, Nature.
[29] V. Blanquet,et al. Physical map around the retinoblastoma gene: possible genomic imprinting suggested by NruI digestion. , 1991, Genomics.
[30] R. Weinberg,et al. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment , 1991, Cell.
[31] J. Cowell,et al. Application of PCR amplification of DNA from paraffin embedded tissue sections to linkage analysis in familial retinoblastoma. , 1991, Journal of medical genetics.
[32] B. Horsthemke,et al. Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma. , 1991, American journal of medical genetics.
[33] W. Gullick,et al. Inactivation of the retinoblastoma gene does not lead to loss of TGF-beta receptors or response to TGF-beta in breast cancer cell lines. , 1991, Oncogene.
[34] M. Sporn,et al. Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. Benedict,et al. Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression. , 1991, Oncogene.
[36] W. Lee,et al. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. , 1991, The EMBO journal.
[37] J. Cowell,et al. Genetic counselling in retinoblastoma: importance of ocular fundus examination of first degree relatives and linkage analysis. , 1991, The British journal of ophthalmology.
[38] F. Kaye,et al. Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.
[39] K. Redmond,et al. Clinical presentation, treatment, and outcome of trilateral retinoblastoma , 1991, Cancer.
[40] A. Okamoto,et al. Variable mutations of the RB gene in small-cell lung carcinoma. , 1990, Oncogene.
[41] W. Lee,et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Robbins,et al. Negative regulation of human c-fos expression by thes retinoblastoma gene product , 1990, Nature.
[43] J. Massagué,et al. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation , 1990, Cell.
[44] M. Jay,et al. Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom. , 1990, Archives of disease in childhood.
[45] M. Ewen,et al. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product , 1990, Molecular and cellular biology.
[46] W. Lee,et al. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.
[47] S. Naylor,et al. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. , 1990, Cancer research.
[48] G. Klein,et al. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[49] N. Dyson,et al. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.
[50] R. Weinberg,et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[51] W. Lee,et al. PCR-based detection of a polymorphic BamHI site in intron 1 of the human retinoblastoma (RB) gene. , 1990, Nucleic acids research.
[52] W. Lee,et al. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.
[53] J M Trent,et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. , 1990, Science.
[54] B. Gallie,et al. A physical map around the retinoblastoma gene. , 1990, Genomics.
[55] B. Gallie,et al. Use of the RB1 cDNA as a diagnostic probe in retinoblastoma families , 1990, Clinical genetics.
[56] G. S. Cowley,et al. Detection of the XbaI RFLP within the retinoblastoma locus by PCR , 1990, Nucleic Acids Res..
[57] E. Buckley,et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. , 1989, The New England journal of medicine.
[58] B. Gallie,et al. Mutations in the RB1 gene and their effects on transcription , 1989, Molecular and cellular biology.
[59] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[60] P. Grabham,et al. The expression of the retinoblastoma gene product Rb1 in primary and adenovirus-transformed human cells. , 1989, Oncogene.
[61] H. Tien,et al. Cytogenetic evidence of multifocal origin of a unilateral retinoblastoma. A help in genetic counseling. , 1989, Cancer genetics and cytogenetics.
[62] T. Dryja,et al. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. , 1989, American journal of human genetics.
[63] David M. Livingston,et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.
[64] E. Harlow,et al. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.
[65] Phang-lang Chen,et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.
[66] G. Draper,et al. Non-ocular cancer in relatives of retinoblastoma patients. , 1989, British Journal of Cancer.
[67] K. Tan,et al. Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of mutation, revealed by combined use of markers within and flanking the RB1 gene. , 1989, American journal of human genetics.
[68] T. L. McGee,et al. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. , 1989, Gene.
[69] A. Goddard,et al. Preferential germline mutation of the paternal allele in retinoblastoma , 1989, Nature.
[70] Lee Wh,et al. Studies of the retinoblastoma gene in human sarcomas. , 1989 .
[71] W. Lee,et al. Structure of the human retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[72] T. Dryja,et al. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[73] T. Dryja,et al. Parental origin of mutations of the retinoblastoma gene , 1989, Nature.
[74] W. J. Brammar,et al. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. , 1989, Oncogene.
[75] R. Weinberg,et al. Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.
[76] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[77] E. Harlow,et al. Cellular targets for transformation by the adenovirus E1A proteins , 1989, Cell.
[78] Chun-Ming Huang,et al. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family , 1989, Cell.
[79] W. Cavenee,et al. Molecular detection of chromosomal translocations that disrupt the putative retinoblastoma susceptibility locus , 1989, Molecular and cellular biology.
[80] P. L. Chen,et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.
[81] B. Gallie,et al. Identification of germline and somatic mutations affecting the retinoblastoma gene. , 1988, Science.
[82] J. Minna,et al. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.
[83] Wen-Hwa Lee,et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.
[84] K. Ishizaki,et al. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. , 1988, Cancer research.
[85] Stephen H. Friend,et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product , 1988, Nature.
[86] W. Lee,et al. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.
[87] D. Brunoni,et al. Bilateral retinoblastoma associated with 13q-mosaicism. Possible manifestation of a germinal mutation. , 1988, Cancer genetics and cytogenetics.
[88] B. Gallie,et al. Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors , 1988, Molecular and cellular biology.
[89] K. Nicolaides,et al. PRENATAL EXCLUSION OF HEREDITARY RETINOBLASTOMA , 1988, The Lancet.
[90] A. Craft,et al. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. , 1988, The New England journal of medicine.
[91] R. Weinberg,et al. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[92] J. Opitz,et al. Deletion (13) (q14.1q14.3) in two generations: Variability of ocular manifestations and definition of the phenotype , 1987 .
[93] Wen-Hwa Lee,et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity , 1987, Nature.
[94] M. Jay,et al. A chromosomal breakpoint that separates the esterase D and retinoblastoma predisposition loci in a patient with del(13)(q14q31). , 1987, Cancer genetics and cytogenetics.
[95] S. Hinrichs,et al. Structural evidence for the authenticity of the human retinoblastoma gene. , 1987, Science.
[96] M. Jay,et al. An assessment of the usefulness of electrophoretic variants of esterase-D in the antenatal diagnosis of retinoblastoma in the United Kingdom. , 1987, British Journal of Cancer.
[97] W. Lee,et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.
[98] Stephen H. Friend,et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.
[99] T. Dryja,et al. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[100] B. Gallie,et al. Tumour induction by the retinoblastoma mutation is independent of N-myc expression , 1986, Nature.
[101] R. Ellsworth,et al. Chromosomal abnormalities in human retinoblastoma a review , 1986, Cancer.
[102] J. Kingston,et al. Second primary neoplasms in patients with retinoblastoma. , 1986, British Journal of Cancer.
[103] Keith Cg,et al. Retinoblastoma and Retinoma Occurring in a Child With a Translocation and Deletion of the Long Arm of Chromosome 13 , 1985 .
[104] S. Latt,et al. Molecular and cytologic analysis of DNA amplification in retinoblastoma. , 1985, Cancer genetics and cytogenetics.
[105] B. Gallie,et al. Genetic origin of mutations predisposing to retinoblastoma. , 1985, Science.
[106] C. Junien,et al. Cytogenetic forms of retinoblastoma: their incidence in a survey of 66 patients. , 1985, Cancer genetics and cytogenetics.
[107] A. Knudson. Hereditary cancer, oncogenes, and antioncogenes. , 1985, Cancer research.
[108] Wen-Hwa Lee,et al. Expression and amplification of the N-myc gene in primary retinoblastoma , 1984, Nature.
[109] S. Latt,et al. Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. , 1984, Cancer genetics and cytogenetics.
[110] Raymond L. White,et al. Homozygosity of chromosome 13 in retinoblastoma. , 1984, The New England journal of medicine.
[111] T. P. Dryja,et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.
[112] B. Gallie,et al. Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma , 1983, Nature.
[113] A. Sandberg,et al. Chromosome 6 in malignant melanoma. , 1983, Cancer genetics and cytogenetics.
[114] W. Benedict,et al. Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. , 1983, Science.
[115] M. Sasaki,et al. Possible inactivation of part of chromosome 13 due to 13qXp translocation associated with retinoblastoma , 1982, Clinical genetics.
[116] B. Gallie,et al. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? , 1982, British Journal of Cancer.
[117] L. Rorke,et al. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. , 1982, Cancer genetics and cytogenetics.
[118] L. Strong,et al. Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. , 1981, Science.
[119] W. Benedict,et al. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. , 1980, Science.
[120] T. Hida,et al. Bilateral retinoblastoma with a 13qXp translocation. , 1980, Journal of pediatric ophthalmology and strabismus.
[121] W. W. Nichols,et al. Further observations on a 13qXp translocation associated with retinoblastoma. , 1980, American journal of ophthalmology.
[122] U. Francke,et al. Partial triplication and deletion of 13q: study of a family presenting with bilateral retinoblastomas , 1979, Clinical genetics.
[123] J. Yunis,et al. Retinoblastoma and subband deletion of chromosome 13. , 1978, American journal of diseases of children.
[124] R. Ellsworth,et al. Pleiotropic effects of the gene for retinoblastoma , 1974, Journal of medical genetics.
[125] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[126] A. Sorsby,et al. THE GENETICS OF RETINOBLASTOMA* , 1944, The British journal of ophthalmology.
[127] R. Takahashi,et al. Genomic organization of the human retinoblastoma gene. , 1989, Oncogene.
[128] J. Cowell,et al. Predisposition to retinoblastoma due to a translocation within the 4.7R locus. , 1989, Oncogene.
[129] J. Nevins. Mechanisms of viral-mediated trans-activation of transcription. , 1989, Advances in virus research.
[130] M. Jay,et al. Genetic and cytogenetic analysis of patients showing reduced esterase-D levels and mental retardation from a survey of 500 individuals with retinoblastoma. , 1989, Ophthalmic paediatrics and genetics.
[131] B. Horsthemke,et al. Mechanism of i(6p) formation in retinoblastoma tumor cells. , 1989, Cancer genetics and cytogenetics.
[132] J. Yokota,et al. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. , 1988, Oncogene.
[133] F. Mitelman,et al. Amplification of the human putative oncogene INT1 in primary retinoblastoma tumors. , 1988, Cytogenetics and cell genetics.
[134] B. Gallie,et al. Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization. , 1987, Cytogenetics and cell genetics.
[135] R. Ellsworth,et al. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? , 1984, Ophthalmology.
[136] A. Leblanc,et al. Two cases of del(13q)-retinoblastoma and two cases of partial trisomy due to a familial insertion. , 1983, Annales de genetique.
[137] J. Cowell,et al. Double minutes and homogeneously staining regions: gene amplification in mammalian cells. , 1982, Annual review of genetics.
[138] H. Stallard. The conservative treatment of retinoblastoma. , 1962, Transactions of the ophthalmological societies of the United Kingdom.